These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23541846)

  • 1. Clinical relevance of antineutrophil cytoplasmic antibodies in Algerian scleroderma patients.
    Tahiat A; Djidjik R; Abdessmed A; Mellal Y; Nebbab A; Gharnaout M; Ghaffor M; Ladjouze A
    Joint Bone Spine; 2013 Oct; 80(5):547-8. PubMed ID: 23541846
    [No Abstract]   [Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis.
    Carvajal I; Bernis C; Sanz P; Garcia A; Garcia-Vadillo A; Traver JA
    Nephrol Dial Transplant; 1997 Mar; 12(3):576-7. PubMed ID: 9075145
    [No Abstract]   [Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis.
    Manolova I; Dancheva M
    J Rheumatol; 2003 Sep; 30(9):2078-9; author reply 2079-80. PubMed ID: 12966621
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleroderma associated with ANCA-associated vasculitis.
    Rho YH; Choi SJ; Lee YH; Ji JD; Song GG
    Rheumatol Int; 2006 Mar; 26(5):465-8. PubMed ID: 16012875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature.
    Caramaschi P; Biasi D; Tonolli E; Carletto A; Bambara LM
    Joint Bone Spine; 2002 Mar; 69(2):177-80. PubMed ID: 12027309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis.
    Casari S; Haeney M; Farrand S; Herrick A
    J Rheumatol; 2002 Dec; 29(12):2666-7. PubMed ID: 12465176
    [No Abstract]   [Full Text] [Related]  

  • 7. Scleroderma associated with ANCA-associated vasculitis.
    Rho YH; Choi SJ; Lee YH; Ji JD; Song GG
    Rheumatol Int; 2006 Mar; 26(5):369-75. PubMed ID: 16032390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis.
    Grypiotis P; Cozzi F; Ruffatti A
    J Rheumatol; 2004 Jul; 31(7):1468-9. PubMed ID: 15229985
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic sclerosis associated with ANCA-associated vasculitis accompanied by Henoch-Schönlein purpura.
    Niiyama S; Eto H; Katsuoka K
    Eur J Dermatol; 2013 Apr; 23(2):283-4. PubMed ID: 23587477
    [No Abstract]   [Full Text] [Related]  

  • 10. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
    Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
    J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antineutrophil cytoplasmic antibodies in patients with diffuse diseases of connective tissue].
    Dadonene I; Redaĭtene E; Shaulauskene I; Kirdaĭte G; Vasiliauskene L
    Ter Arkh; 2002; 74(5):38-43. PubMed ID: 12087904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.
    Endo H; Hosono T; Kondo H
    J Rheumatol; 1994 May; 21(5):864-70. PubMed ID: 8064727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antineutrophil cytoplasmic antibodies and associated diseases].
    Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
    Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibodies in systemic sclerosis.
    Kiraz S; Simsek H; Ertenli I; Benekli M; Kadayifci A
    Clin Rheumatol; 1996 Sep; 15(5):519-20. PubMed ID: 8894374
    [No Abstract]   [Full Text] [Related]  

  • 15. Noncrescentic ANCA-associated renal crisis in systemic sclerosis.
    Mimura I; Hori Y; Matsukawa T; Uozaki H; Tojo A; Fujita T
    Clin Nephrol; 2008 Aug; 70(2):183-5. PubMed ID: 18793540
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
    Mizutani A; Tanaka I; Katayama M; Oshima H; Komatsu Y; Asano S; Kato K; Matsumura H; Ishii K; Miyama H; Nagai T; Kato K; Fukaya S; Yoshida S; Hasegawa M; Kawashima S; Torikai K
    Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.
    Chikazawa H; Nishiya K; Matsumori A; Hashimoto K
    J Clin Immunol; 2000 Jul; 20(4):279-86. PubMed ID: 10939715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy.
    Villaverde V; Balsa A; Cabezas JA; Fernández-Prada M; Torre A; Mola EM
    Rheumatology (Oxford); 1999 Feb; 38(2):190-1. PubMed ID: 10342639
    [No Abstract]   [Full Text] [Related]  

  • 19. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension.
    Tomioka M; Hinoshita F; Miyauchi N; Akiyama Y; Saima S; Hiroe M
    Intern Med; 2004 Jun; 43(6):496-502. PubMed ID: 15283187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.